# âœ… PHASE 8: ORCHESTRATOR V2 COMPLETE
**Date:** January 26, 2026  
**Version:** v2.0.0-CORE  
**Status:** âœ… **COMPLETE**

---

## ğŸ¯ PHASE 8 OBJECTIVES (ACHIEVED)

1. âœ… Create Orchestrator v2 entrypoint
2. âœ… Wire all v2.0 modules (Phases 1-6)
3. âœ… Add clear stage logging
4. âœ… Create integration tests
5. âœ… Document pipeline

---

## ğŸ”§ IMPLEMENTATION SUMMARY

### **Orchestrator v2 Created**
âœ… **File:** `PX_Executive/orchestrators/PX_Live_Orchestrator_v2.py`

**Pipeline Stages:**
```
[1] OPE Analysis
[2] ADMET Analysis  
[3] PK/PD Simulation (Population with IIV)
[4] Adaptive Logic (if enabled)
[5] Dose Optimization v2
[6] Virtual Efficacy Analytics
[7] Evidence Package v3
[8] Pipeline Summary
```

### **Architecture**
```python
class PredatorXOrchestratorV2:
    def run_pipeline(smiles, metadata) -> dict:
        # Executes full v2.0 computational pipeline
        # Returns: All stage results + dossier path
```

---

## ğŸ“Š PIPELINE STAGES DETAIL

### **Stage 1: OPE Analysis**
```
Input:  SMILES string
Output: OPE analysis dict (logP, MW, etc.)
Module: PX_Engine.operations.OPE
```

### **Stage 2: ADMET Analysis**
```
Input:  SMILES + OPE
Output: ADMET dict (distribution, metabolism, toxicity)
Module: PX_Engine.operations.ADMET
```

### **Stage 3: PK/PD Simulation**
```
Input:  SMILES + ADMET + protocol + PD params + IIV params
Output: Trial result with PK/PD summaries + IIV distributions
Module: PX_Engine.operations.TrialEngine
Features:
  âœ… PK simulation (Phase 1)
  âœ… PD modeling (Phase 1)
  âœ… Population IIV (Phase 2)
  âœ… Adaptive logic (Phase 3)
```

### **Stage 4: Adaptive Logic (Optional)**
```
Input:  Protocol with adaptive_rules
Output: Adaptation decisions logged in trial_result
Module: PX_Engine.operations.TrialEngine (embedded)
```

### **Stage 5: Dose Optimization v2**
```
Input:  SMILES + ADMET + targets + bounds
Output: Best regimen + search history
Module: PX_Engine.operations.DoseOptimizer_v2
Strategy: Coarse-to-fine search
Evaluations: ~25-40 mini-trials
```

### **Stage 6: Virtual Efficacy Analytics**
```
Input:  Trial result + targets + thresholds
Output: PTA, responder rates, risk assessment
Module: PX_Engine.operations.VirtualEfficacyAnalytics
Metrics:
  âœ… Probability of Target Attainment (PTA)
  âœ… Virtual responder rates
  âœ… Effect variability risk
```

### **Stage 7: Evidence Package v3**
```
Input:  Protocol + trial_result + OPE + ADMET
Output: Partner-grade JSON dossier
Module: PX_System.foundation.Evidence_Package
Schema: v3.0 (with IIV, adaptive, dose_opt, efficacy)
```

### **Stage 8: Summary**
```
Output: Pipeline duration, status, dossier location
```

---

## ğŸ§ª TESTING RESULTS

### **Orchestrator v2 Tests**
âœ… **File:** `PX_Validation/tests/test_orchestrator_v2.py`

**Test Suite:**
```
test_full_pipeline_aspirin                  âœ… PASS
test_pipeline_results_structure             âœ… PASS
test_dose_optimization_integration          âœ… PASS
test_virtual_efficacy_integration           âœ… PASS
test_evidence_package_v3_schema             âœ… PASS
```

**Results:** 5/5 passing (100%)

### **System Integration Verification**
```
Core Tests (Phases 1-6):        134/134 âœ…
System Tests:                    46/46 âœ…
Performance Tests:               4/4 âœ…
Orchestrator v2 Tests:           5/5 âœ…
â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€
TOTAL:                           189/189 âœ… (100%)
```

---

## ğŸš€ USAGE

### **Command Line (Recommended):**
```bash
# Basic usage (SMILES required)
python PX_Executive/orchestrators/PX_Live_Orchestrator_v2.py --smiles "CC(=O)Oc1ccccc1C(=O)O"

# With metadata
python PX_Executive/orchestrators/PX_Live_Orchestrator_v2.py \
  --smiles "CC(=O)Oc1ccccc1C(=O)O" \
  --name "Aspirin" \
  --id "ASPIRIN-001" \
  --indication "Analgesic"

# Complex molecule
python PX_Executive/orchestrators/PX_Live_Orchestrator_v2.py \
  --smiles "CC1=CC(=CC(=C1)[C@@H]2CCCN2CC3=CC=C(C=C3)OC4=C(C=C(C=C4)C(=O)N)F)C"

# Quiet mode (suppress verbose output)
python PX_Executive/orchestrators/PX_Live_Orchestrator_v2.py \
  --smiles "CC(=O)Oc1ccccc1C(=O)O" \
  --quiet

# Help
python PX_Executive/orchestrators/PX_Live_Orchestrator_v2.py --help
```

### **Programmatic Usage:**
```python
from PX_Executive.orchestrators.PX_Live_Orchestrator_v2 import PredatorXOrchestratorV2

orchestrator = PredatorXOrchestratorV2(verbose=True)

results = orchestrator.run_pipeline(
    smiles="CC(=O)Oc1ccccc1C(=O)O",  # Aspirin
    metadata={"id": "ASPIRIN-001", "name": "Aspirin"}
)

print(f"Dossier: {results['dossier_path']}")
```

---

## ğŸ“ˆ PERFORMANCE

**Typical Pipeline Execution:**
```
Small molecule (Aspirin):       ~0.08 seconds
Medium complexity:              ~0.2 seconds
Large/complex molecule:         ~0.5 seconds
```

**Stage Breakdown:**
```
OPE:                    <0.01s
ADMET:                  <0.01s
PK/PD Trial:            ~0.01s (21 patients)
Dose Optimization:      ~0.05s (25 evaluations)
Virtual Efficacy:       <0.01s
Evidence Package:       <0.01s
```

---

## ğŸ“Š OUTPUT STRUCTURE

### **Pipeline Results Dict:**
```json
{
  "version": "v2.0.0-CORE",
  "smiles": "...",
  "metadata": {...},
  "pipeline_start": "2026-01-26T...",
  "pipeline_end": "2026-01-26T...",
  "duration_seconds": 0.08,
  
  "ope": {...},
  "admet": {...},
  "trial_result": {...},
  "dose_optimization": {
    "best_regimen": {...},
    "search_history": [...],
    "evaluations": 25
  },
  "virtual_efficacy": {
    "pk_pta": {...},
    "pd_responders": {...},
    "effect_risk": {...}
  },
  "dossier_path": "PX_Warehouse/TrialSimulations/..."
}
```

### **Generated Files:**
```
PX_Warehouse/TrialSimulations/
â””â”€â”€ TRIAL_SIMULATION_DOSSIER-<hash>.json  (v3.0 dossier)

PX_Audit/pipeline_runs/
â””â”€â”€ pipeline_run_<timestamp>.json  (full results)
```

---

## ğŸ”’ CONSTITUTIONAL COMPLIANCE

### **All Stages:**
- âœ… Virtual/computational only
- âœ… No clinical endpoints
- âœ… No fabricated values
- âœ… L51/L34 compliant
- âœ… Full provenance tracking

### **Dossier v3 Schema:**
- âœ… Version: 3.0
- âœ… Includes: IIV analysis
- âœ… Includes: Adaptive decisions
- âœ… Includes: Dose optimization
- âœ… Includes: Virtual efficacy
- âœ… Constitutional metadata complete

---

## ğŸ’¼ PARTNER READINESS

**What Partners Receive:**
1. âœ… **Complete computational pipeline**
   - SMILES â†’ Partner-grade dossier
   - ~0.1 seconds per molecule

2. âœ… **Comprehensive analytics**
   - PK/PD modeling
   - Population variability
   - Dose optimization
   - Efficacy predictions

3. âœ… **CRO-ready dossiers (v3.0)**
   - All stages documented
   - Full provenance
   - Constitutional compliance
   - JSON format (machine-readable)

---

## ğŸ“ FILES CREATED/MODIFIED

### **Created:**
```
PX_Executive/orchestrators/
â””â”€â”€ PX_Live_Orchestrator_v2.py  (~250 lines)

PX_Validation/tests/
â””â”€â”€ test_orchestrator_v2.py  (5 tests)

PX_Audit/reports/
â””â”€â”€ ORCHESTRATOR_v2_COMPLETE.md  (this document)
```

### **Not Modified:**
- Legacy orchestrator preserved
- All existing modules unchanged
- Backward compatibility maintained

---

## ğŸ¯ PHASE 8 STATUS

```
â•”â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•—
â•‘               PHASE 8 COMPLETION STATUS                      â•‘
â• â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•£
â•‘ Orchestrator v2:           âœ… CREATED                        â•‘
â•‘ Pipeline Stages:           âœ… ALL WIRED (7 stages)           â•‘
â•‘ Logging:                   âœ… CLEAR & DETERMINISTIC          â•‘
â•‘ Integration Tests:         âœ… 5/5 PASSING                    â•‘
â•‘ System Tests:              âœ… 189/189 PASSING                â•‘
â•‘ Documentation:             âœ… COMPLETE                        â•‘
â•‘                                                              â•‘
â•‘ Overall Status:            âœ… PHASE 8 COMPLETE               â•‘
â•šâ•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•â•
```

---

## âœ… ADVANCEMENT CRITERIA (ALL MET)

- âœ… Orchestrator v2 created and functional
- âœ… All v2.0 modules integrated (Phases 1-6)
- âœ… Clear stage-by-stage logging
- âœ… Integration tests passing (5/5)
- âœ… Full system tests passing (189/189)
- âœ… Documentation complete
- âœ… Ready for Phase 9

---

**Phase 8 Completed:** January 26, 2026  
**Status:** âœ… READY TO ADVANCE TO PHASE 9  
**Next Phase:** Final Validation & Release

---

**ğŸ‰ PHASE 8: ORCHESTRATOR V2 INTEGRATION COMPLETE ğŸ‰**
